The Latest Breaking News from IQV

IQVIA Holdings has underperformed the broader market this year, but Wall Street analysts are bullish about the stock’s prospects.

IQVIA Holdings has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.

The increased demand for healthcare services and technological advancements are poised to keep the healthcare industry buoyed in the foreseeable future. Given this backdrop, are medical stocks Danaher Corporation (DHR), IQVIA Holdings (IQV), and Bio-Rad Laboratories (BIO) worth buying now? Read on to find more….

The market turmoil this year, due to the sky-high inflation and the Fed’s hawkish tilt, has led several fundamentally solid large-cap stocks to trade below their intrinsic values. However, we believe quality large-cap stocks Broadcom (AVGO), Abbott (ABT), IQVIA (IQV), Agilent (A), and QUALCOMM (QCOM), which have declined significantly in…

Integration of advanced technologies and analytics in diagnosing chronic diseases at their early stages has helped the medical diagnostics and research industry grow substantially over the past few years. Growing demand and rising investments in R&D should help prominent players in this space, IQVIA Holdings (IQV) and Mettler-Toledo (MTD), benefit.…

IQVIA Holdings Inc (NYSE:IQV) posted Q1 sales of $3.57 billion, up 4.7% on a reported basis and 6.8% at constant currency (CC), slightly above the consensus of $3.55 billion. Technology & Analytics Solutions revenue increased 6.8% (9.8% CC) to $1.44 billion.  Research & Development Solutions (R&DS) sales reached $1.93 billion, +3.5% (4.7%…

The cloud computing market is expanding as companies innovate and find new ways to incorporate advanced technologies in their operations. Since the cloud computing industry is expected to grow tremendously in the coming years, we think it could be wise to bet now on quality stocks IQVIA Holdings (IQV), F5…

  IQVIA Hldgs (NYSE:IQV) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Over the past 3 months, 6 analysts have published their opinion on IQVIA Hldgs (NYSE:IQV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings: